Douglas Andrew Lanoue, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 912 W. Seminary Ave, Onarga, IL 60955 Phone: 815-268-4843 Fax: 815-268-4845 |
News Archive
With a little practice on a computer or iPad-25 minutes a day, 4 days a week, for 2 months-our brains can learn to see better, according to a study of University of California, Riverside baseball players reported in the Cell Press journal Current Biology on February 17.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
PRB Pharmaceuticals and Lee's Pharmaceuticals have announced that a recent study by Taiwan researchers from the National Health Research Institutes demonstrates TF2b and TF3, two components of v38 AMF-1, inhibit the 3C-like protease encoded by SARS-CoV. v38 AMF-1, a fraction of the flu medication VIRA 38, is best known for its ability to inhibit bird flu virus (H5N1) infections.
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Resolving the world's major challenges whether climate change, environmental pollution, urbanisation, our ageing population or resource scarcity requires a sweeping shift in our approach to sustainability research and education, a group of leading scientists told European policy makers today during the launch of their report "Responses to Environmental and Societal Challenges for our Unstable Earth" (RESCUE).
› Verified 6 days ago